Brucella-Agglutination-Test brucella test

DrSwarnaLatha1 0 views 21 slides Oct 09, 2025
Slide 1
Slide 1 of 21
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21

About This Presentation

Brucella test


Slide Content

Brucella Agglutination Test Serological test for brucellosis

Brucella Agglutination Test Serological test for brucellosis Detects antibodies against Brucella species Essential diagnostic tool Important for epidemiological surveillance

Introduction to Brucellosis Disease Overview: Zoonotic infection Caused by Brucella species Global public health concern Occupational hazard risk Common Species: B. melitensis B. abortus B. suis B. canis

Test Principles Basic Mechanism: Agglutination reaction Antibody-antigen complexes IgM and IgG detection Titer determination Types of Tests: Standard Tube Agglutination (SAT) Rose Bengal Plate Test (RBPT) 2-Mercaptoethanol Test (2-ME) Coombs Anti-Brucella Test

Sample Requirements Collection: 5 mL venous blood Clean venipuncture Proper labeling Transport conditions Processing: Serum separation Heat inactivation Storage requirements Sample stability

Standard Tube Agglutination Test (SAT) Procedure Steps: Serial dilutions (1:20 to 1:1280) Add antigen suspension Incubate at 37°C Observe agglutination Determine end-point titer Quality Controls: Positive control Negative control Antigen control Saline control

Rose Bengal Plate Test Method: Rapid screening test Equal volumes of serum and antigen Rotate for 4 minutes Observe agglutination Interpretation: Positive: Clear agglutination Negative: No agglutination Confirmation needed High sensitivity

2-Mercaptoethanol Test Purpose: Differentiates acute from chronic infection Detects IgG antibodies Eliminates IgM interference Treatment monitoring Procedure: Add 2-ME to serum Perform standard agglutination Compare with untreated serum Interpret results

Result Interpretation Titer Significance: <1:80: Negative 1:160: Suspicious ≥1:320: Positive Endemic area variations Clinical Correlation: Symptoms Exposure history Geographic location Previous infection

Quality Control Measures Internal Controls: Known positive sera Known negative sera Antigen controls Procedural controls External Quality Assurance: Proficiency testing Inter-laboratory comparison Documentation Staff training

Clinical Applications Primary Uses: Diagnosis of acute brucellosis Chronic infection monitoring Treatment response Epidemiological surveys Special Situations: Occupational screening Endemic area testing Research studies Outbreak investigation

Limitations and Interferences Test Limitations: Cross-reactions Prozone phenomenon False positives False negatives Interfering Factors: Recent vaccination Other bacterial infections Autoimmune conditions Technical errors

Safety Considerations Laboratory Safety: Biosafety level 2 practices Personal protective equipment Proper waste disposal Spill management Sample Handling: Universal precautions Proper labeling Safe transport Storage protocols

Documentation Requirements Essential Records: Patient demographics Collection details Test methodology Results and interpretation Report Elements: Titer values Reference ranges Clinical comments Authentication

Troubleshooting Common Problems: Non-specific agglutination Prozone effect Control failures Technical issues Solutions: Repeat testing Different dilutions Fresh reagents Technical review

Modern Developments New Technologies: ELISA methods Flow cytometry Molecular techniques Automated systems Future Directions: Point-of-care testing Digital result reporting Enhanced sensitivity Rapid techniques

Special Considerations Endemic Areas: Modified cut-off values Population prevalence Regular screening Follow-up protocols High-Risk Groups: Veterinarians Farm workers Laboratory staff Food handlers

Treatment Monitoring Serial Testing: Baseline titers Monthly monitoring Expected decline Treatment failure indicators Documentation: Treatment history Titer changes Clinical response Follow-up schedule

Epidemiological Applications Surveillance: Disease prevalence Outbreak detection Control measures Prevention strategies Data Collection: Case definition Result tracking Geographic distribution Risk factors

Training Requirements Technical Skills: Sample processing Test performance Result interpretation Quality control Knowledge Base: Test principles Clinical significance Safety procedures Troubleshooting

Best Practices and Guidelines Standard Procedures: Follow manufacturer guidelines Maintain quality control Proper documentation Regular maintenance Recommendations: Regular staff training Updated procedures Quality assurance Result verification Key Points: Proper technique crucial Quality control essential Clinical correlation needed Regular monitoring required
Tags